Stephen B. Dunnett

1 month ago | nature.com | Roger Barker |Stephen B. Dunnett |Naomi Hannaway |Xiaoling He |Sam Hewitt |Philipp Mahlknecht | +4 more

AbstractTransplantation of human fetal ventral mesencephalic tissue in individuals with Parkinson’s disease has yielded clinical benefits but also side effects, such as graft-induced dyskinesias. The open-label TransEuro trial (NCT01898390) was designed to determine whether this approach could be further developed into a clinically useful treatment.